{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T18:09:23Z","timestamp":1692554963807},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00105-020-04740-x","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T11:03:01Z","timestamp":1608548581000},"page":"71-80","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antinukle\u00e4re Antik\u00f6rper"],"prefix":"10.1007","volume":"72","author":[{"given":"Bettina","family":"Santler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Ehrchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,21]]},"reference":[{"key":"4740_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/315179","author":"M Mahler","year":"2014","unstructured":"Mahler\u00a0M, Meroni\u00a0PL, Bossuyt\u00a0X et al (2014) Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J\u00a0Immunol Res. https:\/\/doi.org\/10.1155\/2014\/315179","journal-title":"J Immunol Res"},{"key":"4740_CR2","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1001\/archinte.164.22.2435","volume":"164","author":"S Narain","year":"2004","unstructured":"Narain\u00a0S, Richards\u00a0HB, Satoh\u00a0M et\u00a0al (2004) Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting. Arch Intern Med 164:2435\u20132441","journal-title":"Arch Intern Med"},{"key":"4740_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.amjmed.2012.09.014","volume":"126","author":"AM Abeles","year":"2013","unstructured":"Abeles\u00a0AM, Abeles\u00a0M (2013) The clinical utility of a\u00a0positive antinuclear antibody test result. Am J Med 126:342\u2013348","journal-title":"Am J Med"},{"key":"4740_CR4","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/art.1780400909","volume":"40","author":"EM Tan","year":"1997","unstructured":"Tan\u00a0EM, Feltkamp\u00a0TE, Smolen\u00a0JS et\u00a0al (1997) Range of antinuclear antibodies in \u201chealthy\u201d individuals. Arthritis Rheum 40:1601\u20131611","journal-title":"Arthritis Rheum"},{"key":"4740_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","volume":"6","author":"EK Chan","year":"2015","unstructured":"Chan\u00a0EK, Damoiseaux\u00a0J, Carballo\u00a0OG et al (2015) Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp\u20112 cell patterns 2014\u20132015. Front Immunol 6:412","journal-title":"Front Immunol"},{"key":"4740_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12016-009-8190-6","volume":"40","author":"A Brucato","year":"2011","unstructured":"Brucato\u00a0A, Cimaz\u00a0R, Caporali\u00a0R et al (2011) Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies. Clin Rev Allergy Immunol 40:27\u201341","journal-title":"Clin Rev Allergy Immunol"},{"key":"4740_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/art.30084","volume":"63","author":"HA Mariz","year":"2011","unstructured":"Mariz\u00a0HA, Sato\u00a0EI, Barbosa\u00a0SH et al (2011) Pattern on the antinuclear antibody-HEp\u20112 test is a\u00a0critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 63:191\u2013200","journal-title":"Arthritis Rheum"},{"key":"4740_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1080\/03009740701406577","volume":"36","author":"R Dinser","year":"2007","unstructured":"Dinser\u00a0R, Braun\u00a0A, Jendro\u00a0MC et al (2007) Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms. Scand J Rheumatol 36:448\u2013451","journal-title":"Scand J Rheumatol"},{"key":"4740_CR9","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle\u00a0MR, Mcclain\u00a0MT, Rubertone\u00a0MV et\u00a0al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N\u00a0Engl J Med 349:1526\u20131533","journal-title":"N Engl J Med"},{"key":"4740_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/jamadermatol.2013.9026","volume":"150","author":"IT Wieczorek","year":"2014","unstructured":"Wieczorek\u00a0IT, Propert\u00a0KJ, Okawa\u00a0J et\u00a0al (2014) Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus. JAMA Dermatol 150:291\u2013296","journal-title":"JAMA Dermatol"},{"key":"4740_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge\u00a0Z, Mchugh\u00a0N (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J\u00a0Intern Med 280:8\u201323","journal-title":"J Intern Med"},{"key":"4740_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00105-018-4353-9","volume":"70","author":"C Drerup","year":"2019","unstructured":"Drerup\u00a0C, Ehrchen\u00a0J (2019) Raynaud\u2019s phenomenon : practical management for dermatologists. Hautarzt 70:131\u2013141","journal-title":"Hautarzt"},{"key":"4740_CR13","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Koenig","year":"2008","unstructured":"Koenig\u00a0M, Joyal\u00a0F, Fritzler\u00a0MJ et al (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a\u00a0twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 58:3902\u20133912","journal-title":"Arthritis Rheum"},{"key":"4740_CR14","first-page":"1","volume":"30","author":"A Wo\u017aniacka","year":"2013","unstructured":"Wo\u017aniacka\u00a0A, Salamon\u00a0M, Mccauliffe\u00a0D et\u00a0al (2013) Antinuclear antibodies in rosacea patients. Postepy Dermatol Alergol 30:1\u20135","journal-title":"Postepy Dermatol Alergol"},{"key":"4740_CR15","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1067\/mai.2000.107039","volume":"105","author":"RL Ochs","year":"2000","unstructured":"Ochs\u00a0RL, Muro\u00a0Y, Si\u00a0Y et\u00a0al (2000) Autoantibodies to DFS 70 kd\/transcription coactivator p75 in atopic dermatitis and other conditions. J\u00a0Allergy Clin Immunol 105:1211\u20131220","journal-title":"J Allergy Clin Immunol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-020-04740-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T12:20:21Z","timestamp":1610540421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-020-04740-x"}},"subtitle":["Praktische Empfehlungen zur Diagnostik durch den Dermatologen"],"short-title":[],"issued":{"date-parts":[[2020,12,21]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4740"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04740-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,21]]},"assertion":[{"value":"21 December 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>B.\u00a0Santler<\/b>: A.\u00a0Finanzielle Interessen: B.\u00a0Santler gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellte Assistenz\u00e4rztin f\u00fcr Dermatologie, Hautklinik der Universit\u00e4tsklinik M\u00fcnster, Von-Esmarch-Stra\u00dfe\u00a058, 48149 M\u00fcnster. <b>J.\u00a0Ehrchen<\/b>: A.\u00a0Finanzielle Interessen: J.\u00a0Ehrchen gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt, Dermatologie, Hautklinik der Universit\u00e4tsklinik M\u00fcnster, Von-Esmarch-Stra\u00dfe\u00a058, 48149 M\u00fcnster.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}